| Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues JM Bronstein, M Tagliati, RL Alterman, AM Lozano, J Volkmann, A Stefani, ... Archives of Neurology 68 (2), 165-171, 2011 | 1096 | 2011 |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ... New England Journal of Medicine 361 (13), 1268-1278, 2009 | 1003 | 2009 |
| LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews LJ Ozelius, G Senthil, R Saunders-Pullman, E Ohmann, A Deligtisch, ... New England Journal of Medicine 354 (4), 424-425, 2006 | 801 | 2006 |
| Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial WJ Marks, RT Bartus, J Siffert, CS Davis, A Lozano, N Boulis, J Vitek, ... The Lancet Neurology 9 (12), 1164-1172, 2010 | 680 | 2010 |
| Botulinum toxin type A in the treatment of upper extremity spasticity A randomized, double‐blind, placebo‐controlled trial DM Simpson, DN Alexander, CF O'Brien, M Tagliati, AS Aswad, JM Leon, ... Neurology 46 (5), 1306-1306, 1996 | 568 | 1996 |
| Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers MS Okun, M Tagliati, M Pourfar, HH Fernandez, RL Rodriguez, ... Archives of Neurology 62 (8), 1250-1255, 2005 | 477 | 2005 |
| Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial MS Okun, BV Gallo, G Mandybur, J Jagid, KD Foote, FJ Revilla, ... The Lancet Neurology 11 (2), 140-149, 2012 | 408 | 2012 |
| Neurologic manifestations of HIV infection DM Simpson, M Tagliati Annals of Internal Medicine 121 (10), 769-785, 1994 | 320 | 1994 |
| Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. DM Simpson, M Tagliati Journal of acquired immune deficiency syndromes and human retrovirology …, 1995 | 293 | 1995 |
| Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration IU Isaias, RL Alterman, M Tagliati Brain 131 (7), 1895-1902, 2008 | 232 | 2008 |
| Impaired sequence learning in carriers of the DYT1 dystonia mutation MF Ghilardi, M Carbon, G Silvestri, V Dhawan, M Tagliati, S Bressman, ... Annals of Neurology 54 (1), 102-109, 2003 | 212 | 2003 |
| Deep brain stimulation for primary generalized dystonia: long-term outcomes IU Isaias, RL Alterman, M Tagliati Archives of Neurology 66 (4), 465-470, 2009 | 210 | 2009 |
| Subthalamic deep brain stimulation and impulse control in Parkinson’s disease TD Hälbig, W Tse, PG Frisina, BR Baker, E Hollander, H Shapiro, ... European Journal of Neurology 16 (4), 493-497, 2009 | 210 | 2009 |
| Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings M Tagliati, J Grinnell, J Godbold, DM Simpson Archives of Neurology 56 (1), 84-89, 1999 | 184 | 1999 |
| P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300 P Stanzione, F Fattapposta, P Giunti, C D'Alessio, M Tagliati, C Affricano, ... Electroencephalography and Clinical Neurophysiology/Evoked Potentials …, 1991 | 179 | 1991 |
| Calculating total electrical energy delivered by deep brain stimulation systems AM Koss, RL Alterman, M Tagliati, JL Shils Annals of Neurology 58 (1), 168, 2005 | 177 | 2005 |
| Sixty hertz pallidal deep brain stimulation for primary torsion dystonia RL Alterman, J Miravite, D Weisz, JL Shils, SB Bressman, M Tagliati Neurology 69 (7), 681-688, 2007 | 147 | 2007 |
| Treatment of levodopa‐induced motor complications F Stocchi, M Tagliati, CW Olanow Movement disorders: official journal of the Movement Disorder Society 23 (S3 …, 2008 | 136 | 2008 |
| Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis G Pagano, G Rengo, G Pasqualetti, GD Femminella, F Monzani, ... J Neurol Neurosurg Psychiatry 86 (7), 767-773, 2015 | 128 | 2015 |
| Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease S Kedia, E Moro, M Tagliati, AE Lang, R Kumar Neurology 63 (12), 2410-2412, 2004 | 127 | 2004 |
Michael S. OkunAdelaide Lackner Professor of Neurology, Executive Director, Norman Fixel Institute for NeurologicalBestätigte E-Mail-Adresse bei neurology.ufl.edu
